Chargement en cours...
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Cystic fibrosis (CF) is a complex genetic disease characterized by death from loss of lung function. Therapies target pathophysiologic changes associated with pulmonary disease progression. Although therapeutic mechanisms differ, efficacy demonstration is limited to a few accepted outcome measures,...
Enregistré dans:
| Publié dans: | Clin Investig (Lond) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486293/ https://ncbi.nlm.nih.gov/pubmed/26146539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/cli.11.174 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|